10-Q Filing

TRANSMEDICS GROUP, INC. CIK: 1756262 Q1 2020

Filing Information

Form Type	10-Q
Accession Number	`0001193125-20-135029`
Period End Date	20200331
Filing Date	20200506
Fiscal Year	2020
Fiscal Period	Q1
XBRL Instance	tmdx-20200331.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 69 Income Statement 32 Cash Flow Statement 68 Stockholders Equity 18 Comprehensive Income 9

Balance Sheet 69 line items

Line Item	Tag	Value	Unit	Period
Preferred Stock, No Par Value	`PreferredStockNoParValue`	-	USD	Point-in-time
Preferred Stock, No Par Value	`PreferredStockNoParValue`	-	USD	Point-in-time
Preferred Stock Authorized	`PreferredStockSharesAuthorized`	25.00M	shares	Point-in-time
Preferred Stock Authorized	`PreferredStockSharesAuthorized`	25.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$20.09M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$24.74M	USD	Point-in-time
Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$12.21M	USD	Point-in-time
Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Marketable Securities	`MarketableSecuritiesCurrent`	$60.60M	USD	Point-in-time
Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Marketable Securities	`MarketableSecuritiesCurrent`	$47.82M	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$6.56M	USD	Point-in-time
Common Stock, Par or Stated Value Per Share	`CommonStockParOrStatedValuePerShare`	-	USD	Point-in-time
Common Stock, Par or Stated Value Per Share	`CommonStockParOrStatedValuePerShare`	-	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$6.13M	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Inventory	`InventoryNet`	$11.22M	USD	Point-in-time
Inventory	`InventoryNet`	$11.36M	USD	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	21.18M	shares	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	21.34M	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$1.66M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$1.54M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$91.70M	USD	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	21.18M	shares	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	21.34M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$100.00M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$4.79M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$4.71M	USD	Point-in-time
Restricted cash	`RestrictedCashNoncurrent`	$500.00K	USD	Point-in-time
Restricted cash	`RestrictedCashNoncurrent`	$500.00K	USD	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	$6.00K	USD	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	$6.00K	USD	Point-in-time
Total assets	`Assets`	$96.92M	USD	Point-in-time
Total assets	`Assets`	$105.30M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$7.25M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$4.86M	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesAndOtherLiabilities`	$9.93M	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesAndOtherLiabilities`	$8.33M	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$164.00K	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$166.00K	USD	Point-in-time
Current portion of deferred rent	`DeferredRentCreditCurrent`	$89.00K	USD	Point-in-time
Current portion of deferred rent	`DeferredRentCreditCurrent`	$370.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$15.04M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$16.11M	USD	Point-in-time
Long-term debt, net of discount and current portion	`LongTermDebtNoncurrent`	$34.27M	USD	Point-in-time
Long-term debt, net of discount and current portion	`LongTermDebtNoncurrent`	$34.15M	USD	Point-in-time
Deferred rent, net of current portion	`DeferredRentCreditNoncurrent`	$389.00K	USD	Point-in-time
Deferred rent, net of current portion	`DeferredRentCreditNoncurrent`	$932.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$50.65M	USD	Point-in-time
Total liabilities	`Liabilities`	$50.24M	USD	Point-in-time
Commitments and contingencies (Note 10)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 10)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, no par value; 25,000,000 shares authorized; no shares issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, no par value; 25,000,000 shares authorized; no shares issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, no par value; 150,000,000 shares authorized; 21,343,480 shares and 21,184,524 shares issued and outstanding at March 31, 2020 and December 28, 2019, respectively	`CommonStockValue`	$424.79M	USD	Point-in-time
Common stock, no par value; 150,000,000 shares authorized; 21,343,480 shares and 21,184,524 shares issued and outstanding at March 31, 2020 and December 28, 2019, respectively	`CommonStockValue`	$424.13M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$227.00K	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-2.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-378.33M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-369.48M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$54.65M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$-199.04M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$46.68M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$-192.24M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$96.92M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$105.30M	USD	Point-in-time

Income Statement 32 line items

Line Item	Tag	Value	Unit	Period
Net revenue	`Revenues`	$7.53M	USD	1 Quarter
Net revenue	`Revenues`	$4.68M	USD	1 Quarter
Cost of revenue	`CostOfRevenue`	$2.10M	USD	1 Quarter
Cost of revenue	`CostOfRevenue`	$2.67M	USD	1 Quarter
Gross profit	`GrossProfit`	$4.86M	USD	1 Quarter
Gross profit	`GrossProfit`	$2.57M	USD	1 Quarter
Research, development and clinical trials	`ResearchAndDevelopmentExpense`	$3.88M	USD	1 Quarter
Research, development and clinical trials	`ResearchAndDevelopmentExpense`	$6.22M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$6.65M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$4.65M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$8.54M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$12.88M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-8.02M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-5.96M	USD	1 Quarter
Interest expense	`InterestExpense`	$1.09M	USD	1 Quarter
Interest expense	`InterestExpense`	$1.04M	USD	1 Quarter
Change in fair value of preferred stock warrant liability	`FairValueAdjustmentOfWarrants`	-	USD	1 Quarter
Change in fair value of preferred stock warrant liability	`FairValueAdjustmentOfWarrants`	$-273.00K	USD	1 Quarter
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$-103.00K	USD	1 Quarter
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$217.00K	USD	1 Quarter
Total other expense, net	`NonoperatingIncomeExpense`	$-923.00K	USD	1 Quarter
Total other expense, net	`NonoperatingIncomeExpense`	$-825.00K	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-8.84M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-6.88M	USD	1 Quarter
Provision for income taxes	`CurrentIncomeTaxExpenseBenefit`	$10.00K	USD	1 Quarter
Provision for income taxes	`CurrentIncomeTaxExpenseBenefit`	$10.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-6.89M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-8.85M	USD	1 Quarter
Net loss per share attributable to common stockholders, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.42	USD	1 Quarter
Net loss per share attributable to common stockholders, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-4.86	USD	1 Quarter
Weighted average common shares outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	21.22M	shares	1 Quarter
Weighted average common shares outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	1.42M	shares	1 Quarter

Cash Flow Statement 68 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-6.89M	USD	1 Quarter
Net loss	`ProfitLoss`	$-8.85M	USD	1 Quarter
Net loss	`ProfitLoss`	$-33.50M	USD	Annual
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$245.00K	USD	1 Quarter
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$371.00K	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$57.00K	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$385.00K	USD	1 Quarter
Change in fair value of preferred stock warrant liability	`FairValueAdjustmentOfWarrants`	-	USD	1 Quarter
Change in fair value of preferred stock warrant liability	`FairValueAdjustmentOfWarrants`	$-273.00K	USD	1 Quarter
Non-cash interest expense and end of term accretion expense	`NonCashInterestAndEndOfTermAccretionExpense`	$115.00K	USD	1 Quarter
Non-cash interest expense and end of term accretion expense	`NonCashInterestAndEndOfTermAccretionExpense`	$123.00K	USD	1 Quarter
Net amortization of premiums on marketable securities	`AmortizationOfDebtDiscountPremium`	$1.00K	USD	1 Quarter
Unrealized foreign currency transaction losses	`ForeignCurrencyTransactionGainLossUnrealized`	$-160.00K	USD	1 Quarter
Unrealized foreign currency transaction losses	`ForeignCurrencyTransactionGainLossUnrealized`	$-78.00K	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-422.00K	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$1.75M	USD	1 Quarter
Inventory	`IncreaseDecreaseInInventories`	$241.00K	USD	1 Quarter
Inventory	`IncreaseDecreaseInInventories`	$2.47M	USD	1 Quarter
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-417.00K	USD	1 Quarter
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$120.00K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-2.41M	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$758.00K	USD	1 Quarter
Accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$1.81M	USD	1 Quarter
Accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$2.39M	USD	1 Quarter
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$57.00K	USD	1 Quarter
Deferred rent	`IncreaseDecreaseInDeferredCharges`	$87.00K	USD	1 Quarter
Deferred rent	`IncreaseDecreaseInDeferredCharges`	$-262.00K	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-8.18M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-7.27M	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$3.00K	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$277.00K	USD	1 Quarter
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$4.17M	USD	1 Quarter
Proceeds from sales and maturities of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$17.16M	USD	1 Quarter
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-3.00K	USD	1 Quarter
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$12.71M	USD	1 Quarter
Payments of initial public offering costs and other financing costs	`PaymentsOfStockIssuanceCosts`	$705.00K	USD	1 Quarter
Payments of initial public offering costs and other financing costs	`PaymentsOfStockIssuanceCosts`	$120.00K	USD	1 Quarter
Proceeds from issuance of common stock upon exercise of stock options	`ProceedsFromStockOptionsExercised`	$8.00K	USD	1 Quarter
Proceeds from issuance of common stock upon exercise of stock options	`ProceedsFromStockOptionsExercised`	$75.00K	USD	1 Quarter
Proceeds from issuance of common stock in connection with employee stock purchase plan	`ProceedsFromStockPlans`	$197.00K	USD	1 Quarter
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$152.00K	USD	1 Quarter
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-697.00K	USD	1 Quarter
Effect of exchange rate changes on cash, cash equivalents and restricted cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-45.00K	USD	1 Quarter
Effect of exchange rate changes on cash, cash equivalents and restricted cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-60.00K	USD	1 Quarter
Net increase (decrease) in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-8.03M	USD	1 Quarter
Net increase (decrease) in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$4.65M	USD	1 Quarter
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$20.74M	USD	Point-in-time
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$20.59M	USD	Point-in-time
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$12.71M	USD	Point-in-time
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$25.24M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$20.74M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$20.59M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$12.71M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$25.24M	USD	Point-in-time
Transfers of inventory to property and equipment	`InventoryTransferToPropertyPlantAndEquipment`	$78.00K	USD	1 Quarter
Transfers of inventory to property and equipment	`InventoryTransferToPropertyPlantAndEquipment`	$407.00K	USD	1 Quarter
Purchases of property and equipment included in accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	$129.00K	USD	1 Quarter
Purchases of property and equipment included in accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	$112.00K	USD	1 Quarter
Offering costs included in accounts payable and accrued expenses	`DeferredOfferingCostsIncludedInAccountsPayableAndAccruedExpenses`	$1.13M	USD	1 Quarter
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$20.09M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$24.74M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$12.21M	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalents`	$500.00K	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalents`	$500.00K	USD	Point-in-time
Total cash, cash equivalents and restricted cash shown in the statement of cash flows	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$20.74M	USD	Point-in-time
Total cash, cash equivalents and restricted cash shown in the statement of cash flows	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$20.59M	USD	Point-in-time
Total cash, cash equivalents and restricted cash shown in the statement of cash flows	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$12.71M	USD	Point-in-time
Total cash, cash equivalents and restricted cash shown in the statement of cash flows	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$25.24M	USD	Point-in-time

Stockholders Equity 18 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquity`	$54.65M	USD	Point-in-time
Balance	`StockholdersEquity`	$-199.04M	USD	Point-in-time
Balance	`StockholdersEquity`	$46.68M	USD	Point-in-time
Balance	`StockholdersEquity`	$-192.24M	USD	Point-in-time
Issuance of common stock upon the exercise of common stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$8.00K	USD	1 Quarter
Issuance of common stock upon the exercise of common stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$75.00K	USD	1 Quarter
Issuance of common stock in connection with employee stock purchase plan	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$197.00K	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$57.00K	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$385.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$16.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$34.00K	USD	1 Quarter
Unrealized gains on marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$213.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-6.89M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-8.85M	USD	1 Quarter
Balance	`StockholdersEquity`	$54.65M	USD	Point-in-time
Balance	`StockholdersEquity`	$-199.04M	USD	Point-in-time
Balance	`StockholdersEquity`	$46.68M	USD	Point-in-time
Balance	`StockholdersEquity`	$-192.24M	USD	Point-in-time

Comprehensive Income 9 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-6.89M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-8.85M	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$16.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$34.00K	USD	1 Quarter
Unrealized gains on marketable securities, net of tax of $0	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$213.00K	USD	1 Quarter
Total other comprehensive income	`OtherComprehensiveIncomeLossNetOfTax`	$34.00K	USD	1 Quarter
Total other comprehensive income	`OtherComprehensiveIncomeLossNetOfTax`	$229.00K	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-6.86M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-8.62M	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.